Soluble adhesion molecules in serum and cyst fluid from patients with cystic tumours of the ovary

Human Reproduction

Volumn 13, Issue 10, 1998, Pages 2831-2835

  Daraï, Emile ^a,b   Bringuier, Annie France ^b   Walker Combrouze, Francine ^a   Feldmann, Gérard ^a,b   Madelenat, Patrick ^a   Scoazec, Jean Yves ^a,b  

^a BICHAT HOSPITAL   (France)

^b INSERM   (France)

Author keywords

Adhesion molecules; Cadherins; CD44; ICAM 1; Ovarian tumours

Indexed keywords

CD44V ANTIGEN; CELL ADHESION MOLECULE; INTERCELLULAR ADHESION MOLECULE 1; UVOMORULIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYST FLUID; CYSTADENOMA; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CARCINOMA; OVARY CYST; OVARY TUMOR; PROTEIN BLOOD LEVEL; TERATOMA;

EID: 0031760045     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/13.10.2831     Document Type: Article

References (32)

1. Albelda, S.M. (1993) Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab. Invest., 68, 4-11.
2. Andersen, W.A., Nichols, O.E., Avery, S.R., et al. (1995) Cytologic diagnosis of ovarian tumors: factors influencing accuracy in previously undiagnosed cases. Am. J. Obstet. Gynecol., 173, 457-464.
3. Banks, R.E., Gearing, A.J.H. and Hemingway, I.K. (1993) Circulating ICAM-1, E-selectin and VCAM-1 in human malignancies. Br. J. Cancer, 68, 122-124.
4. Cannistra, S.A., Abu-Jawdeh, G., Niloff, J. et al. (1995) CD44 variant expression is a common feature of epithelial ovarian cancer; lack of association with standard prognostic factors. J. Clin. Oncol., 13, 1912-1921.
5. Chapron, C., Dubuisson, J.-B., Fritel, X. et al. (1996) Diagnosis and management of organic ovarian cysts: indications and procedures forlaparoscopy. Hum. Reprod. Update, 2, 435-446.
6. Daraï, E., Scoazec, J.-Y., Walker-Combrouze, F. et al. (1997) Expression of cadherins in benign, borderline and malignant ovarian epithelial tumors: a clinicopathological study. Human Pathol., 28, 922-928.
7. Daraï, E., Walker-Combrouze, F., Fauconnier, A. et al. (1998) Analysis of CD44 expression in serous and mucinous borderline tumours of the ovary: comparison with cystadenomas and overt carcinomas. Histopathology, 32, 151-159.
8. Fleuren, G.J., Nap, M., Aalders, J.G. et al. (1987) Explanation of the limited correlation between tumor CA-125 content and serum CA-125 antigen levels in patients with ovarian tumors. Cancer, 60, 2437-2442.
9. Gao, Y.-J., Liu, G., Wang, X. et al. (1994) Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer. Cancer Res., 54, 422-426.
10. Geier, G. and Strecker, J.R. (1981) Aspiration cytology and E2 content in ovarian tumors. Acta Cytol., 25, 400-406.
11. Giavazzi, R., Nicoletti, M.I., Chirivi, R.G.S. et al. (1994) Soluble ICAM-1 is released into the serum and ascites of human ovarian carcinoma patients and in nude mice bearing tumor xenografts. Eur. J. Cancer, 30A, 1865-1870.
12. Hart, W.R. and Norris, H.J. (1973) Borderline and malignant mucinous tumors of the ovary. Histologic criteria and clinical behavior. Cancer, 31, 1031-1045.
13. Hyodo, I., Jinno, K., Tanimizu, M. et al. (1993) Detection of circulating ICAM-1 in hepatocellular carcinoma. Int. J. Cancer, 55, 775-779.
14. Inotiev M., Ogawa, H., Miyata, M. et al. (1992) Expression of E-cadherin in normal, benign, and malignant tissues of female genital organs. Am. J. Clin. Pathol., 98, 76-80.
15. International Federation of Gynecology and Obstetrics, Oncology Committee (1987) Changes in definitions of clinical staging for carcinoma of the cervix and ovary. Am. J. Obstet. Gynecol., 156, 263-264.
16. Jackson, A.M., Alexandrov, A.B., Gribben, S.C. et al. (1993) Expression and shedding of ICAM-1 in bladder cancer and its immunotherapy. Int. J. Cancer, 55, 921-925.
17. Johnson, J.P. (1991) Cell adhesion molecules of the immunoglobulin superfamily and their role in malignant transformation and progression to metastatic disease. Cancer Metastasis Rev., 10, 11-22.
18. Kainz, C., Kohlbergef, P., Tempfer, C. et al. (1995) Serum CD44 splice. variants in cervical cancer patients. Cancer Lett., 90, 231-234
19. Matsumura, K., Kawanishi, I., Fujii, S. et al. (1992) Altered expression of E-cadherin in gastric cancer tissues and carcinomatous fluid. Br. J. Cancer, 66, 1122-1130.
20. Matsumura, Y. and Tarin, D. (1992) Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet, 350, 1053-1058.
21. Menczer, J., Ben-Baruch, G., Moran, O. et al. (1993) Cyst fluid CA 125 levels in ovarian epithelial neoplasms. Obstet. Gynecol., 81, 25-28.
22. Montag, T.W. (1990) Tumor markers in gynecologic oncology. Obstet. Gynecol. Surv., 45, 94-105.
23. Naiman, M. (1995) Laparoscopic removal of the adnexal mass: the case for caution. Clin. Obstet. Gynecol., 38, 370-379.
24. Parker, W.H. (1992) Management of adnexal masses by operative laparoscopy. Selection criteria. J. Reprod. Med., 37, 603-606.
25. Parker, W.H., Levine, R.L., Howard, F.M. et al. (1994) A multicenter study of laparoscopic management of selected cystic adnexal masses in postmenopausal women. J. Am. Coll. Surg., 179, 733-737.
26. Risinger, J.I., Berchuk, A., Kohler, M.F. et al. (1994) Mutations of the E- cadherin gene in human gynecologic cancers. Nature Genet., 7, 98-102.
27. Ristamaki, R., Joensuu, H., Salm, M. et al. (1994) Serum CD44 in malignant lymphoma: an association with treatment response. Blood, 84, 238-243.
28. Seth, R., Raymond, F.D. and Makguba, M.W. (1991) Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders. Lancet, 338, 83-84.
29. Sliutz, G., Tempfer, C., Winkler, S. et al. (1995) Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer. Br. J. Cancer, 72, 1494-1497.
30. Tarin, D. and Matsumura, Y. (1994) Recent advances in the study of tumour invasion and metastasis. J. Clin. Pathol., 47, 385-390.
31. Trope, C. (1981) The preoperative diagnosis of malignancy of ovarian cysts. Neoplasia, 28, 117-121.
32. Uhl-Steidl, M., Müller-Holzner, E., Zeimet, A.G. et al. (1995) Prognostic value of CD44 splice variant expression in ovarian cancer. Oncology, 52, 400-406.